The remarkable restoration of the wound-healing capacity of the HT29 ATG16L1 knockdown cell lines treated with 6-TG may be important in the increased potential of thiopurines in ATG16L1 T300A homozygous Crohn's disease patients compared to ATG16L1 WT Crohn's disease patients. This evidence concerns the gene ATG16L1 and Crohn disease.